ABUS vs INVH · P/E 5.4, rev $6.2M vs P/E 42, rev $2.62B
Arbutus Biopharma Corp (ABUS) versus Invitation Homes Inc (INVH) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Invitation Homes Inc (INVH) is a reit - residential company listed on US.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported INVH revenue for 2024-12-31 was $2.62B. Net income was $455.4M. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. INVH currently screens at market cap $19.99B and trailing P/E 41.8.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. INVH currently screens at market cap $19.99B and trailing P/E 41.8.
Not investment advice. Open the ABUS and INVH stock pages for the full models.
Not investment advice.